Pharmaceuticals News and Research

RSS

PMS, Novatek collaborate to provide integrated contamination control solution for manufacturing processes

Particle Measuring Systems, a global expert in sterility assurance, and Novatek International, the leader in regulatory compliant data management software, today announced a global partnership providing a fully integrated and comprehensive software and hardware solution towards a risk-based approach for the environmental monitoring in controlled manufacturing processes.

18 Sep 2017

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

Hospital pharmacist Mandy Langston remembers when Lulabelle Berry arrived at Stone County Medical Center's emergency department last year.

18 Sep 2017

IMB researchers make breakthrough in understanding origin of aging process

Researchers at the Institute of Molecular Biology in Mainz, Germany, have made a breakthrough in understanding the origin of the aging process. They have identified that genes belonging to a process called autophagy - one of the cells most critical survival processes - promote health and fitness in young worms but drive the process of aging later in life.

15 Sep 2017

New analysis sheds light on struggles faced by carers in the UK

A new analysis taken from a global survey of 3,086 carers has cast new light on the struggles carers in the UK face today. The analysis reveals the majority of caregivers in the UK are relatively new to caring, with most taking care of someone for five years or less, furthermore, the data reveals 34% are millennials (between the ages of 18 – 34).

15 Sep 2017

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.

14 Sep 2017

Pharmaceutical compound from leaves of coralberry may help combat asthma

The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways.

14 Sep 2017

Almirall presents new corporate identity along with strong focus on skin health

Almirall, S.A., presented its new corporate identity today, with which it reinforces its position as a pharmaceutical company specialized in Science and its commitment to providing medical solutions for its customers.

14 Sep 2017

BC Platforms introduces new resource that enables integrated analytics of genomic and clinical data

BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data.

14 Sep 2017

Modified blood thinner may be first promising method to prevent repercussions after TBI

A chemically modified version of the common blood thinner heparin may be the first promising method of preventing the harmful cascade of destruction to brain tissue that commonly follows traumatic brain injury (TBI), according to new research findings.

13 Sep 2017

Podcast: ‘What the Health?’ health plans busting out all over

In a busy health week for Congress, Republicans and Democrats on the Senate Finance Committee agreed on a proposal to fund the Children's Health Insurance Program for five more years, while Republicans and Democrats at the Health, Education, Labor, and Pensions Committee continued to pursue a joint plan to stabilize the individual health insurance market.

13 Sep 2017

Arkansas professor makes strides toward developing enhanced cancer treatment

A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.

13 Sep 2017

FDA moves to guard against abuse of ‘orphan drug’ program

The Food and Drug Administration is changing the way it approves medicines known as "orphan drugs" after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.

13 Sep 2017

NIH awards $15 million to develop 3D microphysiological system platforms that model human disease

More than 60 percent of investigational drugs fail in human clinical trials due to a lack of effectiveness, despite promising pre-clinical studies using cell and animal research models.

13 Sep 2017

VUMC and Bayer agree on strategic research alliance to develop new therapies for kidney diseases

Vanderbilt University Medical Center and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.

12 Sep 2017

Meningitis B vaccine’s high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

8 Sep 2017

Eli Lilly to lay off 8.5 percent of employees in bid to cut costs

Eli Lilly and Company announced yesterday that they have decided to lay off around 8.5 percent of their employees. The company was on its way to develop two potential major drugs over the past year but set backs have led to major financial losses, leading to this decision.

7 Sep 2017

CFDA's NIFDC and IIVS re-affirm, expand partnership to bring non-animal test methods to China

Bo Li, Director General Director of the CFDA's National Institute for Food and Drug Control and Erin Hill, President of US based non-profit, Institute for In Vitro Sciences, Inc., signed a Memorandum of Understanding to bring non-animal test methods to China for the regulation of cosmetics and ingredients.

7 Sep 2017

Controlling zinc transporter levels could be effective plan to combat pancreatic cancer, other diseases

When trace elements rise to toxic levels, bad things happen. Patients suffering from Alzheimer's and Parkinson's disease harbor significantly higher levels of zinc and iron in their brains than healthy patients.

6 Sep 2017

Study identifies genetic alterations with potential to promote aggressiveness of astrocytomas

Among the various types of cancerous brain tumors, 70% are astrocytomas. Fatal in as many as 90% of cases, astrocytomas originate in the largest and most numerous cells in the central nervous system, called astrocytes because of their star shape.

6 Sep 2017

X36 Series from Mettler-Toledo offers adaptable x-ray inspection for new levels of flexibility

As food and pharmaceutical manufacturers strive to ensure maximum efficiency on their processing lines to maintain competitiveness, the X36 Series from Mettler-Toledo Safeline X-ray can help. This series of adaptable x-ray inspection systems uses the most advanced imaging technology on the market to provide high-detection sensitivity appropriate to a broad range of packaged applications.

From Mettler-Toledo International Inc. 6 Sep 2017

Pharmaceuticals News and Research

PMS, Novatek collaborate to provide integrated contamination control solution for manufacturing processes

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

IMB researchers make breakthrough in understanding origin of aging process

New analysis sheds light on struggles faced by carers in the UK

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

Pharmaceutical compound from leaves of coralberry may help combat asthma

Almirall presents new corporate identity along with strong focus on skin health

BC Platforms introduces new resource that enables integrated analytics of genomic and clinical data

Modified blood thinner may be first promising method to prevent repercussions after TBI

Podcast: ‘What the Health?’ health plans busting out all over

Arkansas professor makes strides toward developing enhanced cancer treatment

FDA moves to guard against abuse of ‘orphan drug’ program

NIH awards $15 million to develop 3D microphysiological system platforms that model human disease

VUMC and Bayer agree on strategic research alliance to develop new therapies for kidney diseases

Meningitis B vaccine’s high price tag poses a health care conundrum

Eli Lilly to lay off 8.5 percent of employees in bid to cut costs

CFDA's NIFDC and IIVS re-affirm, expand partnership to bring non-animal test methods to China

Controlling zinc transporter levels could be effective plan to combat pancreatic cancer, other diseases

Study identifies genetic alterations with potential to promote aggressiveness of astrocytomas

X36 Series from Mettler-Toledo offers adaptable x-ray inspection for new levels of flexibility

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring